| Literature DB >> 11483227 |
M Poljak1, I J Marin, K Seme, V Brinovec, M Maticic, J Meglic-Volkar, G Lesnicar, A Vince.
Abstract
The performance of the Digene Hybrid Capture II HBV DNA Test HC II and the Roche Cobas Amplicor Monitor Test (Cobas-HBV) was evaluated on 252 serum samples. One hundred and seventy-three samples were HBV DNA positive and 75 HBV DNA negative by both assays. Four samples were HBV DNA positive by Cobas-HBV only. Linear regression analysis showed that the HBV DNA concentrations obtained from both assays were significantly related (n=173, r=0.976, P<0.0001). The results of the study show that Hybrid capture II and Cobas-HBV could be used equally in the management for patients with chronic HBV infection.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11483227 DOI： 10.1016/s0166-0934(01)00359-7
Source DB: PubMed Journal: J Virol Methods ISSN： 0166-0934 Impact factor: 2.014